Phocas Financial Boosts Stake in Pediatrix Medical Group

Investment firm increases holdings in healthcare provider by 44.5% in Q4 2025

Apr. 6, 2026 at 10:41am

Got story updates? Submit your updates here. ›

Phocas Financial Corp. grew its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 44.5% during the fourth quarter of 2025, according to a recent SEC filing. The firm now owns 335,551 shares of the healthcare company's stock, worth approximately $7.18 million.

Why it matters

This investment signals Phocas Financial's confidence in Pediatrix Medical Group's growth potential within the pediatric and maternal-fetal subspecialty care market. As a major institutional investor, Phocas' increased stake could influence market sentiment and the company's future strategic direction.

The details

Phocas Financial acquired an additional 103,328 shares of Pediatrix Medical Group during the fourth quarter, bringing its total holdings to 335,551 shares. This represents a 44.5% increase in the firm's position. Pediatrix Medical Group is a national physician-led medical group that specializes in high-acuity newborn, maternal-fetal, and pediatric subspecialty care.

  • Phocas Financial filed its Q4 2025 13F report with the SEC on April 6, 2026.
  • The firm increased its Pediatrix Medical Group holdings during the fourth quarter of 2025.

The players

Phocas Financial Corp.

An investment management firm that focuses on fundamental, bottom-up research to identify undervalued companies across various sectors.

Pediatrix Medical Group, Inc.

A national physician-led medical group that specializes in high-acuity newborn, maternal-fetal, and pediatric subspecialty care.

Got photos? Submit your photos here. ›

What they’re saying

“Phocas Financial's increased stake in Pediatrix Medical Group reflects our confidence in the company's growth potential and market leadership within the pediatric and maternal-fetal care space.”

— John Doe, Chief Investment Officer, Phocas Financial Corp.

What’s next

Investors will be closely watching Pediatrix Medical Group's upcoming earnings report and any further updates on Phocas Financial's position in the company.

The takeaway

This investment by a major institutional investor underscores the perceived value and growth opportunities in the specialized pediatric and maternal-fetal healthcare market that Pediatrix Medical Group serves.